-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
LivaNova (NASDAQ:LIVN) Trading Up 3.5%
LivaNova (NASDAQ:LIVN) Trading Up 3.5%
LivaNova PLC (NASDAQ:LIVN – Get Rating) shares were up 3.5% during trading on Friday . The stock traded as high as $50.05 and last traded at $50.05. Approximately 1,406 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 371,263 shares. The stock had previously closed at $48.37.
Wall Street Analysts Forecast Growth
Several analysts have commented on LIVN shares. Needham & Company LLC lowered their price target on LivaNova from $106.00 to $88.00 and set a "buy" rating for the company in a report on Thursday, August 4th. StockNews.com upgraded LivaNova from a "hold" rating to a "buy" rating in a report on Friday, September 9th. Finally, The Goldman Sachs Group decreased their target price on LivaNova from $85.00 to $73.00 and set a "buy" rating for the company in a report on Tuesday, August 16th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, LivaNova has a consensus rating of "Buy" and a consensus target price of $90.20.
Get LivaNova alerts:LivaNova Stock Up 5.0 %
The stock has a fifty day moving average price of $58.69 and a 200-day moving average price of $66.24. The firm has a market cap of $2.71 billion, a PE ratio of -90.66 and a beta of 0.91. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.47 and a current ratio of 2.93.
LivaNova (NASDAQ:LIVN – Get Rating) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.51 by $0.02. The firm had revenue of $254.20 million for the quarter, compared to analyst estimates of $249.55 million. LivaNova had a positive return on equity of 9.35% and a negative net margin of 2.74%. LivaNova's revenue for the quarter was down 3.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.52 EPS. Research analysts expect that LivaNova PLC will post 1.91 EPS for the current year.Hedge Funds Weigh In On LivaNova
Several hedge funds and other institutional investors have recently bought and sold shares of LIVN. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in LivaNova during the 1st quarter worth approximately $64,579,000. Loomis Sayles & Co. L P raised its position in shares of LivaNova by 601.5% in the 2nd quarter. Loomis Sayles & Co. L P now owns 601,679 shares of the company's stock valued at $37,587,000 after purchasing an additional 515,914 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of LivaNova by 63.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 993,066 shares of the company's stock valued at $81,263,000 after purchasing an additional 383,973 shares in the last quarter. Marshall Wace LLP raised its position in shares of LivaNova by 397.7% in the 4th quarter. Marshall Wace LLP now owns 461,729 shares of the company's stock valued at $40,370,000 after purchasing an additional 368,955 shares in the last quarter. Finally, Teacher Retirement System of Texas raised its position in shares of LivaNova by 121.4% in the 2nd quarter. Teacher Retirement System of Texas now owns 307,501 shares of the company's stock valued at $19,210,000 after purchasing an additional 168,616 shares in the last quarter. 98.89% of the stock is owned by institutional investors and hedge funds.
About LivaNova
(Get Rating)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Featured Articles
- Get a free copy of the StockNews.com research report on LivaNova (LIVN)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Thor Industries Hammers Out A Bottom
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.
LivaNova PLC (NASDAQ:LIVN – Get Rating) shares were up 3.5% during trading on Friday . The stock traded as high as $50.05 and last traded at $50.05. Approximately 1,406 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 371,263 shares. The stock had previously closed at $48.37.
在周五的交易中,Liva Nova PLC(纳斯达克代码:LIVN-GET Rating)的股价上涨了3.5%。该股最高交易价格为50.05美元,最新报50.05美元。午盘交易中,约有1,406股易手,较371,263股的日均成交量下降了100%。该股此前收盘价为48.37美元。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
Several analysts have commented on LIVN shares. Needham & Company LLC lowered their price target on LivaNova from $106.00 to $88.00 and set a "buy" rating for the company in a report on Thursday, August 4th. StockNews.com upgraded LivaNova from a "hold" rating to a "buy" rating in a report on Friday, September 9th. Finally, The Goldman Sachs Group decreased their target price on LivaNova from $85.00 to $73.00 and set a "buy" rating for the company in a report on Tuesday, August 16th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, LivaNova has a consensus rating of "Buy" and a consensus target price of $90.20.
几位分析师对livn的股票发表了评论。Needham&Company LLC在8月4日周四的一份报告中将Liva Nova的目标价从106.00美元下调至88美元,并将该公司的评级定为“买入”。在9月9日星期五的一份报告中,StockNews.com将LivaNova的评级从持有上调至买入。最后,高盛夫妇将Liva Nova的目标价从85.00美元下调至73.00美元,并在8月16日(星期二)的一份报告中为该公司设定了买入评级。根据MarketBeat.com的数据,六位投资分析师对该股的评级为买入,LivaNova的共识评级为买入,共识目标价为90.20美元。
LivaNova Stock Up 5.0 %
Liva Nova股价上涨5.0%
The stock has a fifty day moving average price of $58.69 and a 200-day moving average price of $66.24. The firm has a market cap of $2.71 billion, a PE ratio of -90.66 and a beta of 0.91. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.47 and a current ratio of 2.93.
该股的50日移动均价为58.69美元,200日移动均价为66.24美元。该公司市值27.1亿美元,市盈率为-90.66,贝塔系数为0.91。该公司的负债权益比率为0.36,速动比率为2.47,流动比率为2.93。
Hedge Funds Weigh In On LivaNova
对冲基金对LivaNova的看法
Several hedge funds and other institutional investors have recently bought and sold shares of LIVN. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in LivaNova during the 1st quarter worth approximately $64,579,000. Loomis Sayles & Co. L P raised its position in shares of LivaNova by 601.5% in the 2nd quarter. Loomis Sayles & Co. L P now owns 601,679 shares of the company's stock valued at $37,587,000 after purchasing an additional 515,914 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of LivaNova by 63.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 993,066 shares of the company's stock valued at $81,263,000 after purchasing an additional 383,973 shares in the last quarter. Marshall Wace LLP raised its position in shares of LivaNova by 397.7% in the 4th quarter. Marshall Wace LLP now owns 461,729 shares of the company's stock valued at $40,370,000 after purchasing an additional 368,955 shares in the last quarter. Finally, Teacher Retirement System of Texas raised its position in shares of LivaNova by 121.4% in the 2nd quarter. Teacher Retirement System of Texas now owns 307,501 shares of the company's stock valued at $19,210,000 after purchasing an additional 168,616 shares in the last quarter. 98.89% of the stock is owned by institutional investors and hedge funds.
几家对冲基金和其他机构投资者最近买卖了livn的股票。三井住友信托控股公司在第一季度收购了Liva Nova的一个新头寸,价值约64,579,000美元。Loomis Sayles&Co.L P在第二季度将其在Liva Nova的股票头寸提高了601.5%。Loomis Sayles&Co.L P现在持有601,679股该公司股票,价值37,587,000美元,上个季度又购买了515,914股。高盛股份有限公司在第一季度将其在Liva Nova的股票持仓量提高了63.0%。高盛股份有限公司现在持有该公司993,066股股票,价值81,263,000美元,该公司在上个季度又购买了383,973股。马歇尔·华斯有限责任公司在第四季度将其在Liva Nova的股票头寸提高了397.7%。马歇尔·华斯有限责任公司在上个季度额外购买了368,955股后,现在拥有461,729股该公司股票,价值40,37万美元。最后,德克萨斯州教师退休系统在第二季度将其在Liva Nova股票中的头寸提高了121.4%。德克萨斯州教师退休系统在上个季度购买了168,616股后,现在拥有307,501股该公司股票,价值19,210,000美元。98.89%的股票由机构投资者和对冲基金持有。
About LivaNova
关于Liva Nova
(Get Rating)
(获取评级)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Liva Nova PLC是一家医疗设备公司,在全球设计、开发、制造和销售治疗解决方案。它通过三个部分运作:心肺、神经调节和高级循环支持。心肺部门开发、生产和销售心肺产品,包括氧合器、心肺机、自体输血系统、灌流管系统、套管、连接件和其他相关产品。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on LivaNova (LIVN)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Thor Industries Hammers Out A Bottom
- 免费获取StockNews.com关于Liva Nova的研究报告(Livn)
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat:回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何?
- 雷神工业走出谷底
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.
接受Liva Nova Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收Liva Nova和相关公司的最新新闻和分析师评级的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧